Skip to main content
Premium Trial:

Request an Annual Quote

David Cooper, Edward McCabe, Geoffrey Duyk, Frank McCormick

Premium

David Cooper, former chief medical officer for NimbleGen Systems of Iceland, has been named to the board of directors of Health Discovery Corp., formerly Direct Wireless Communications, of Waco, Texas, the company said last week. Cooper also was the former chief science officer and chief operating officer for Question Diagnostics, Nichols Institute, in San Juan Capistrano, Calif. He additionally worked as vice president and chief science officer for diaDexus of Santa Clara, Calif. Cooper holds a PhD in chemistry from Florida State University and an MD from the University of Florida, Gainesville.


Edward McCabe has joined the board of advisors at GeneFluidics, of Monterey Park, Calif., the com-pany said Nov. 3. McCabe is chairman of the department of pediatrics at UCLA Medical School. He is also chair of the US Department of Health and Human Services Secretary’s Advisory Committee on Genetics, Health, and Society.


Geoffrey Duyk will leave his post of president, research and development, and chief scientific officer at Exelixis at the end of the year to pursue other professional oppor-tunities, the company said Oct. 30. Frank McCormick, an Exelixis’ board member, will step up his advisory role on the company’s R&D. Duyk joined Exelixis in 1997.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.